The Defense Health Agency awarded a $312,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct research on "Inhibiting Mitochondrial Permeability Transition Pore Opening to Treat Mitochondrial Myopathy" over the period of September 1, 2023 to August 31, 2025. This grant was provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. As a private non-profit educational institution, Thomas Jefferson University has extensive experience conducting federally-funded research in areas such as medical sciences, biomedical research, and military medical research.
Generated 5/7/24, 3:23 AM